#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant neoplasm of choroid Sickle cell anaemia Amyotrophic lateral sclerosis gene carrier Leukoencephalopathy Nasopharyngeal cancer Cervix carcinoma Postprandial hypoglycaemia Chronic myeloid leukaemia (in remission) Sarcoidosis Glomerulonephritis acute Hypersensitivity pneumonitis Enteritis Arrhythmia Prophylaxis against transplant rejection Squamous cell carcinoma of head and neck More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Treatment Progressive multifocal leukoencephalopathy – Treatment Gastrointestinal stromal tumour – Diagnostics Cystic fibrosis lung – Trials in Disease Marfan’s syndrome – Life with Disease Medulloblastoma – Life with Disease Haemophilia A with anti factor VIII – Basic Information KBG syndrome – Trials in Disease Bronchiolitis obliterans syndrome – Treatment Mastocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    F770/05 Jnj-81241459 GOCATAMIG Memantine Hydrochloride Rmc-6291 NORGESTIMATE Threonine Pegvaliase Bi 690517 GSK4418959A Palbociclib Ibuprofen Lactose Adagrasib Omp11 Tamoxifen Citrate Ibutamoren Mesilate Onasemnogene Abeparvovec Calcium Carbonate Soya Oil More therapies…

    Learn about Your Condition

    Colonoscopy Metastasis Pneumothorax Critical illness Anaemia of pregnancy Endometrial cancer stage II Peritoneal neoplasm Biliary adenoma Pulmonary resection Ophthalmoplegia Vasoplegia syndrome Acoustic neuroma Neuropathy peripheral T-cell lymphoma Cognitive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Autoimmune disorder

  • Study Using PET Imaging to See How [89Zr]Zr-DFO-CIT-013 Spreads in Patients with Inflammatory Mediated Immune Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • [89ZR]ZR-DFO-CIT-013
    The Netherlands
  • Study on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • Levetiracetam
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Cyclophosphamide
    Italy
  • Study on Stopping Prednisone for Patients with Inflammatory or Autoimmune Disorders

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autoimmune disorder
    • Inflammation
    Investigated Drugs:
    • Prednisone
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!